Fda authorizes first home COVID-19 and influenza combination tests to collect samples
-
Last Update: 2021-03-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
, the U.S. Food and Drug Administration approved the first diagnostic test for taking patient samples at home to test
COVID-19
influenza A and B.
FDA
Authorized
Quest Diagnostics RC COVID-19 and Flu RT-PCR
Testing with
Quest Diagnostics
Self-Collection Kit
prescriptions for coVID-19 plus
influenza, collected and used at home by individual patients suspected of respiratory virus infections and in accordance with
COVID-19
, are appropriate at the decision of the healthcare provider. On the orders of health care providers, patients can collect samples at home and ship them to the
Quest Diagnostics laboratory for analysis as described
the self-collection kit.“ The recent authorization of home-collected samples for
COVID-19
plus the use of influenza testing is an important step in the
FDA
's nationwide response to
COVID-19
. With the test's mandate, the
FDA
is helping to deal with the ongoing fight against
COVID-19
in the middle of the flu season, which is important for many people, including the most vulnerable Americans. This is another example of
FDA
working with test developers to bring important diagnoses to Americans," said
dr. stephen M. Hahn
,
FDA
Commissioner. In a comfortable and relatively safe home, it provides Americans with answers faster, allowing patients to remain isolated and wait for results. This efficiency can go a long way to providing timely information to patients with unknown respiratory diseases. (
cyy123.com
)original source:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
